Skip to main content
. 2026 Aug 31;62(9):1668. doi: 10.3390/medicina62091668
BMI Body mass index
CI Confidence interval
DFS Disease-free survival
ECF Epirubicin, cisplatin, and fluorouracil
ECX Epirubicin, cisplatin, and capecitabine
ECOG Eastern Cooperative Oncology Group
FLOT Fluorouracil, leucovorin, oxaliplatin, and docetaxel
FOLFOX Fluorouracil, leucovorin, and oxaliplatin
GEJ Gastroesophageal junction
HR Hazard ratio
LVI Lymphovascular invasion
OS Overall survival
pCR Pathological complete response
PNI Perineural invasion
TRG Tumor regression grade